Renal Allografts with IF/TA Display Distinct Expression Profiles of Metzincins and Related Genes

Chronic renal allograft injury is often reflected by interstitial fibrosis (IF) and tubular atrophy (TA) without evidence of specific etiology. In most instances, IF/TA remains an irreversible disorder, representing a major cause of long‐term allograft loss. As members of the protease family metzincins and functionally related genes are involved in fibrotic and sclerotic processes of the extracellular matrix (ECM), we hypothesized their deregulation in IF/TA. Gene expression and protein level analyses using allograft biopsies with and without Banff'05 classified IF/TA illustrated their deregulation. Expression profiles of these genes differentiated IF/TA from Banff'05 classified Normal biopsies in three independent microarray studies and demonstrated histological progression of IF/TA I to III. Significant upregulation of matrix metalloprotease‐7 (MMP‐7) and thrombospondin‐2 (THBS‐2) in IF/TA biopsies and sera was revealed in two independent patient sets. Furthermore, elevated THBS‐2, osteopontin (SPP1) and β‐catenin may play regulatory roles on MMP. Our findings further suggest that deregulated ECM remodeling and possibly epithelial to mesenchymal transition (EMT) are implicated in IF/TA of kidney transplants, and that metzincins and related genes play an important role in these processes. Profiling of these genes may be used to complement IF/TA diagnosis and to disclose IF/TA progression in kidney transplant recipients. Microarray based gene expression profiling reveals deregulation of metzincins, especially overexpression of MMP‐7, in IF/TA and identifies a set of metzincins and related genes that allows classification of biopsies from three independent studies into IF/TA and normal/unremarkable histology.